Papers

1

Total Citations

5

H-Index

1

About

Rebecca Bui is a surgical oncologist whose work is reshaping the treatment landscape for head and neck cancers, particularly oropharyngeal and hypopharyngeal squamous cell carcinoma. Her primary research focuses on advancing minimally invasive surgical techniques, with a special emphasis on transoral robotic surgery (TORS). In her landmark 2024 paper, Bui demonstrates how TORS offers a compelling alternative to traditional open surgery for these challenging malignancies—a critical advance given the global rise in HPV-related oropharyngeal cancers and the historically poor prognosis of hypopharyngeal disease. By showing that robotic approaches can achieve comparable oncologic outcomes while reducing morbidity, her work directly addresses the need for treatments that preserve quality of life without compromising survival. Though early in its citation history, this paper signals a paradigm shift in surgical oncology. Bui’s contributions are particularly timely as they provide evidence-based options for a patient population that is both growing and increasingly younger. Her research stands at the intersection of technological innovation and clinical necessity, positioning her as a rising leader in the field of robotic head and neck surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Transoral Robotic Surgery for Oropharyngeal and Hypopharyngeal Squamous Cell Carcinoma
5 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: The University of Texas Medical Branch at Galveston

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago